Meera Mohan

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Meera Mohan
Apr 26, 2025, 16:07 | Science
Anup Trikannad shares findings on IVIG prophylaxis benefits in BCMA-directed bispecific therapy for MM
Anup Trikannad, Internist in Little Rock, AR, shared a post on X about a paper…
Apr 24, 2025, 10:12 | Science
Myeloma Paper of the Day, April 24th, suggested by Robert Orlowski
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas…
Jan 4, 2025, 13:31 | Insight
Samer Al Hadidi: The longest follow up of any myeloma phase III clinical trial
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on X: “We…
Oct 15, 2024, 13:40 | Insight
Myeloma Paper of the Day, October 15th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Adapted version of the…
Aug 28, 2024, 13:44 | Insight
Myeloma Paper of the Day, August 28th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Multi-center retrospective study shows immune…
Aug 12, 2024, 02:23 | Blog
Rafael Fonseca: Defining CRS and ICANs risks
Rafael Fonseca shared a post by USMIRC News, on X: "Clearly defines risk of CRS and…
Jun 24, 2024, 22:40 | Insight
Mehdi Hamadani: Outpatient administration of every single commercial CAR-T product
Mehdi Hamadani, Director of the BMT and Cellular Therapy Program at the Medical College of…
Jun 20, 2024, 14:09 | Blog
Oliver Van Oekelen: An overview on Sequencing Immunotherapy for Multiple Myeloma
Oliver Van Oekelen, Internal Medicine Resident at Mount Sinai Beth Israel, posted on X: "Immunotherapy has…
All: 8 Posts: 1 - 100
Special Coverage